Accumulated evidence suggests that Parp-1 is involved in DNA repair processes, including base excision repair, single-strand and double-strand break repairs. To understand the precise role of Parp-1 in genomic stability in vivo, we carried out mutation analysis using Parp-1 knockout (Parp-1 À/À ) mice harboring two marker genes, gpt and red/gam genes. Spontaneous mutant frequencies of both genes in the bone marrows and livers did not differ significantly between Parp-1 À/À and Parp-1 þ / þ mice (P>0.05). After treatment with an alkylating agent, Nnitrosobis(2-hydroxypropyl)amine (BHP), the mutant frequency of the red/gam genes in the liver in Parp-1 À/À mice was 1.6-fold higher than that in Parp-1 þ / þ mice (Po0.05). Categorization of the mutations revealed that deletions larger than 1 kb or those accompanying 1-5 bp insertions at the deletion junctions, as well as rearrangements, were more frequently observed in Parp-1 À/À than in Parp-1 þ / þ mice (Po0.05, respectively). In contrast, mutant frequencies of the gpt gene in the livers of Parp-1 À/À and Parp-1 þ / þ mice after BHP treatment were both elevated and there was no significant difference between the genotypes. These results indicate that Parp-1 is implicated in suppressing deletion mutations in vivo, especially those accompanying small insertions or rearrangements.
Introduction
Poly(ADP-ribose) polymerase-1 (Parp-1) is activated by binding to single-strand break (SSB) and double-strand break (DSB) ends, and catalyses polyADP ribosylation of various nuclear proteins, including Parp-1 itself (Yoshihara et al., 1977; Adolph and Song, 1985) , histone (Buki et al., 1995) , p53 (Wesierska-Gadek et al., 1996) , and DNA-dependent protein kinase (DNA-PKcs) (Ariumi et al., 1999) using NAD as a substrate. Parp-1 possesses a BRCT (BRCA1 C-terminal) motif being overlapped with an automodification domain, and binds to various proteins through this domain, including XRCC1 (Masson et al., 1998) , histone (Buki et al., 1995) , and Parp-2 (Schreiber et al., 2002) . Accumulating studies have indicated Parp-1 to be involved in base excision repair (BER) (Caldecott et al., 1996a; Masson et al., 1998) , SSB (Okano et al., 2003) , and DSB repairs through its enzymatic activity and/or protein-protein interaction through the BRCT domain.
In the BER reaction, cleavage of damaged bases takes place and, subsequently, SSB is introduced by the excision of abasic sites by nucleases. Parp-1 binds to SSB ends and is involved in the recruitment of XRCC1 (Caldecott et al., 1996b; Masson et al., 1998; ElKhamisy et al., 2003) , DNA polymerase b (pol b) (Caldecott et al., 1996b; Masson et al., 1998) , and DNA ligase III (Leppard et al., 2003) . In the cell-free system, DNA polymerization by pol b and strand displacement by flap endonuclease-1 (FEN-1) in the long-patch repair is disturbed in the absence of Parp-1 (Vodenicharov et al., 2000; Prasad et al., 2001) . Another study showed a decreased level of long-patch repair in Parp-1 À/À cells, with reduction in the levels of FEN-1 and DNA ligase I (Sanderson and Lindahl, 2002) .
DSB repair is categorized into homologous recombination (HR) repair and nonhomologous end joining (NHEJ) repair pathways. Involvement of Parp-1 in NHEJ repair has been also suggested from the interaction with DNA-PKcs and Ku70/80 (Ariumi et al., 1999; Galande and Kohwi-Shigematsu, 1999) . Parp-1 is also indicated to suppress HR repair, and the frequencies of gene-targeting (Waldman and Waldman, 1990; Semionov et al., 1999 Semionov et al., , 2003 Susse et al., 2004) and sister chromatid exchanges were increased in Parp-1 À/À cells (de Murcia et al., 1997; Wang et al., 1997) and by treatment with Parp inhibitors (Oikawa et al., 1980) . The involvement of Parp-1 in BER and DSB repair, and its suppressive role in HR repair, suggests that deletion or insertion mutations may accumulate under Parp-1 deficiency. On the other hand, it is reported that the gene-targeting frequency was not different between Parp-1 À/À and Parp-1 þ / þ cells, and it is therefore suggested that Parp-1 is dispensable in NHEJ and HR induced by DSBs (Yang et al., 2004) .
Analysis of mutant frequencies and spectra in Parp-1 À/À mice in vivo would be helpful to understand the impact of Parp-1 deficiency on DNA repair and genomic stability. For this purpose, we established Parp-1 À/À mice, harboring a tandem array of 80 copies of lambda EG10 DNA containing two surrogate marker genes by intercrossing with gpt delta transgenic mice (Nohmi et al., 1996) . Point mutations can be detected by gpt assay, and deletion mutations ranging from 1 bp up to 9.1 kbp are able to be efficiently identified in the red/ gam genes by Spi À assay, as shown in Figure 1 Nohmi et al., 1999; Okada et al., 1999) .
In the present study, we analysed spontaneous mutations in the bone marrow and livers of Parp-1
and Parp-1 þ / þ mice. Since Parp-1 À/À mice show higher susceptibility to the lethality induced by alkylating agents (de Murcia et al., 1997; Masutani et al., 2000) , and to the tumorigenicity of agents such as Nnitrosobis(2-hydroxypropyl)amine (BHP) and azoxymethane (Tsutsumi et al., 2001; Nozaki et al., 2003) compared to Parp-1 þ / þ mice, we also analysed mutations after treatment with BHP. We demonstrated that the frequency of deletion mutations, but not point mutations, was higher in BHP-treated Parp-1 À/À than in Parp-1 þ / þ mice (Po0.05). Notably, larger size deletions and complex-type deletions accompanying small insertions or recombination/rearrangement were significantly increased in Parp-1 À/À when compared to Parp-1 þ / þ animals (Po0.05, respectively).
Results
Spontaneous mutations in the bone marrow of Parp-1
In the gpt assay, which detects point mutations in the gpt gene (Figure 1 ), the spontaneous mutation frequencies of the bone marrow in Parp-1 þ / þ and Parp-1 À/À mice (n ¼ 5, respectively) were 6.973.1 ( Â 10 À6 ), and 5.671.2 ( Â 10
À6
). There was no significant difference between Parp-1 þ / þ and Parp-1 À/À mice (P ¼ 0.75). The spectra and distribution patterns of the mutations in the gpt gene were not different between Parp-1 þ / þ and Parp-1
mice (data not shown).
In the Spi À assay, which detects deletion mutations in the red/gam genes (Figure 1 ), mutant frequencies in Parp-1 À/À and Parp-1 þ / þ mice (n ¼ 5, respectively) were 8.071.0 ( Â 10 À6 ) and 6.772.0 ( Â 10 À6 ), respectively, and there was no significant difference between either genotype (P ¼ 0.46). The spectra and the distributions of the mutations in the red/gam genes were analysed with 39 and 27 mutants for Parp-1 À/À and Parp-1 þ / þ animals, respectively. Most of the mutations were deletion mutations of 1-6 bp at single-nucleotide run sequences and there was no difference in the distribution of mutation sites between the genotypes (data not shown).
Increase in Spi
À mutant frequencies in the liver of BHPtreated Parp-1 À/À mice Genomic DNA was prepared from the liver, a major target organ of BHP (Green et al., 1980) . Mutant frequency of the gpt gene in the livers of nontreated mice (n ¼ 4) was 5.770.9 ( Â 10 À6 ) and 1071.8 ( Â 10 À6 ) in Parp-1 þ / þ and Parp-1 À/À mice, respectively. After BHP treatment, mutant frequencies were increased to 8976.4 ( Â 10
À6
) and 66712 ( Â 10 À6 ), respectively. There was no significant difference between the genotypes of the nontreated (P ¼ 0.059) and the BHP-treated mice (P ¼ 0.083) (see Supplementary Information).
Spi À mutant frequencies in nontreated Parp-1 þ / þ and Parp-1 À/À mice were not statistically different (P ¼ 0.083). On the other hand, Spi À mutant frequencies in BHP-treated mice increased to 1672.0 ( Â 10 À6 ) and 2674.2 ( Â 10 À6 ), respectively. The mutant frequency in Parp-1 À/À mice was 1.6-fold higher compared with Parp-1 þ / þ mice (Po0.05, Table 1 ).
Analysis of mutation spectrum
Mutation spectra of 83 and 179 Spi À mutant phages rescued from Parp-1 þ / þ and Parp-1 À/À mice, respectively, were analysed as shown in Table 2 . Most of the Spi À mutations were deletions and the specific mutation frequencies of the total deletion mutations were 1.7-fold higher in Parp-1 À/À than in Parp-1 þ / þ mice, although the Figure 1 Scheme for gpt and Spi À assays for detecting mutations in gpt delta mice. The lambda EG10 phages are rescued from mouse genomic DNA by in vitro packaging. In gpt assay, lambda phages are infected into E. coli strain YG6020 expressing Cre recombinase and 6.4 kb region of lambda EG10, containing the gpt gene, was converted to plasmid. Mutation in gpt genes can be positively selected using a plate containing chloramphenicol and 6-TG. In Spi À assay, lambda phages are infected into E. coli harboring P2 lysogen. Lambda phages containing deletion mutations in red/gam genes can selectively grow and form Spi À mutant plaques Increase of deletion mutations under Parp-1 deficiency A Shibata et al difference was not statistically significant (P ¼ 0.082). The Spi À mutants were classified into three classes based on the deletion sizes, namely deletions of single base, 2 bp-1 kbp, and >1 kbp, and we calculated each specific mutation frequency. The mutation frequencies of deletions larger than 1 kbp in Parp-1 À/À mice were 2.2-fold higher than in Parp-1 þ / þ mice (Po0.05). We also noticed that the specific mutation frequencies of 1-2 bp insertions in the red/gam genes were also 7.9-fold more in Parp-1 À/À than in Parp-1 þ / þ mice (Table 2 ), although the difference was not statistically significant (P ¼ 0.091). Notably, most of these insertions (8/9) were observed in mononucleotide adenine (thymine) runs in Parp-1 À/À mice (Table 3) . These 1 bp insertion and base substitution mutations might not be detected as Spi À mutants if other P2 lysogenic Escherichia coli strain, such as WL95 (P2), were used . In all, 71 and 80% of the single base deletions were located at 2-6 bp runs in Parp-1 þ / þ and Parp-1 À/À mice, respectively, and the sites of single base deletions in the gam gene of Parp-1 À/À mice exhibited a wider distribution pattern, as shown in Figure 2 . The locations of the hot spots for the single base deletions were neither different between genotypes nor from those reported for spontaneous mutations in the liver (Masumura et al., 2002) .
Classification of BHP-induced deletion mutations with two bases or more
There was no difference in the distribution pattern of deletion mutations with two bases or more between the genotypes (Figure 3 ). Deletions of two bases or more were further categorized into simple-or complex-type deletions, including deletions with small insertions of 1-5 bp, recombinations, and rearrangements, by analysis of their deletion region/junction sequences (Table 4) . Although the majority of the deletions were simple deletions both in Parp-1 þ / þ and Parp-1 À/À mice, the (Table 4) . Deletion mutants could be categorized into two types depending on the structures of the deletion junctions. If they harbor microhomology, they could possibly be produced during microhomology-mediated end joining (MEJ) and be classified as MEJ type (Figure 4 ) (Roth and Wilson, 1986) . If the deletion junctions harbor no microhomology, they could possibly originate during non-microhomology-mediated end joining (non-MEJ) and could be classified as non-MEJ type (Figure 4) . In non-MEJ, DNA termini are postulated to be processed to become blunt ended, and then both ends will be held together and ligation of DNA ends will be accomplished (Roth and Wilson, 1986) .
Notably, five out of the six mutants from Parp-1 À/À mice harbored no microhomology at deletion junctions, indicating that they were mostly caused by non-MEJ. Three mutants contained palindromic small insertions at deletion junctions (see the legend of Table 4 ). Seven mutants from Parp-1 À/À and two from Parp-1 (Table 4) were found to contain rearrangements (see Materials and methods for experiments). We also noticed that three mutants from Parp-1 À/À mice accompanied recombinations, which occurred between the deleted regions of the red/gam genes and sequences in lambda EG10 (Table 5 ). As the lambda EG10 sequence is tandemly integrated in the genome, we could not determine whether these complex-type deletions were generated by reciprocal or nonreciprocal recombinations. Interestingly, two out of the three mutants harbored microhomology at the deletion junctions. On the other hand, the deletion in Ls4 G86-2-6 (Table 5) was suggested to occur through two sequential recombinations using 8-10 bp homologous sequences (underlined sequences in Table 5 ). Notably, 'Cttca' at junctional sequences of the deletion was common in two out of the three rearrangements (Table 5) .
The fraction of deletion mutants that harbored short microhomology at the deletion junction, namely MEJ type to the total NHEJ event (the sum of MEJ-type and non-MEJ-type deletions), was 13/30 (43%) and 17/66 (26%) in Parp-1 þ / þ and Parp-1 À/À mice, respectively, showing a tendency for decrease of MEJ-type and increase of non-MEJ-type under Parp-1 deficiency, although the difference is not statistically significant (P ¼ 0.085).
Discussion
The Spi À mutant frequencies were 1.6-fold higher in the liver of Parp-1 À/À compared to Parp-1 þ / þ mice after the treatment with BHP (Po0.05). Most of the mutations were found to be deletion types in both genotypes, and the specific mutation frequencies of deletion showed a 1.7-fold elevation in Parp-1
cases, although the difference was not statistically significant (P ¼ 0.082). We further observed that Parp-1 deficiency enhances deletion mutations, especially more than 1 kbp in size (Po0.05), and complex-type deletions accompanying either insertion or recombination/rearrangement in mice after treatment with BHP (Po0.05). On the other hand, the mutant frequencies in the gpt gene were elevated to the same level in both Parp-1 þ / þ and Parp-1 À/À mice, suggesting that Parp-1 deficiency does not contribute substantially to the increase of point mutations even after treatment with the alkylating agent. The data suggested that Parp-1 deficiency led to the enhancement of deletion mutation frequency after treatment with an alkylating agent, BHP, and this may directly relate to the higher incidence of cancer development. Spontaneous mutant frequencies in bone marrow cells measured by both gpt and Spi À assays were not different between Parp-1 þ / þ and Parp-1 À/À animals at 4 months old (P>0.05, respectively). This was expected since spontaneous tumor incidences, including those of lymphoma, were not elevated in Parp-1 À/À mice at least until 9 months of age , and the elevation of the incidence of hepatocellular carcinoma in Parp-1 À/À mice was reported only at 18-24 months (Tong et al., 2002) . To understand the relationship of mutation and carcinogenesis, it will be helpful to measure mutant frequencies in Parp-1 þ / þ and Parp-1 À/À mice at advanced ages. BHP mainly produces O 6 -and N
7
-methylguanines, and O 6 -and N 7 -hydroxypropylguanines as DNA lesions (Kokkinakis, 1992) . O 6 -and N 7 -methylguanines can be repaired by BER or alkylguanine alkyltransferases, whereas O 6 -and N
-hydroxypropylguanines might be repaired not only by BER but also by nucleotide excision repair (Nivard et al., 2003) . Point mutations in the gpt gene after treatment with BHP are likely to be caused by translesion DNA synthesis through damaged bases. It was notable that the frequencies of 1-2 base adenine (thymine) insertions in the adenine (thymine) mononucleotide run sequences in red/gam genes showed a greater tendency in Parp-1 À/À than in Parp-1 þ / þ mice, although it was not statistically significant. These mutations could be caused by DNA polymerase slippage during replication. There is a possibility that either the frequencies of DNA polymerase slippage are higher or the subsequent mismatch repair is less efficient under Parp-1 deficiency.
In the BER process, damaged bases are initially excised by DNA glycosylases, such as 8-oxoguanine-DNA glycosylase (OGG1) or endonuclease III homolog 1 (NTH1), and, subsequently, a single base gap is (Dantzer et al., 2000) . Parp-1 also interacts with FEN-1, which excises approximately 2-7 base pairs to remove damaged bases in the long-patch repair (Prasad et al., 2001) . The absence of difference in the mutant frequency of the gpt gene between Parp-1 À/À and Parp-1 þ / þ mice (P>0.05, see Supplementary Information) suggested that the BER pathway under Parp-1 deficiency might possibly proceed until the excision of damaged bases.
The increase of deletion mutations accompanying insertion or recombination/rearrangement (Po0.05, see Table 4 ) indicated two possibilities, namely, DSB repair occurred more frequently or the repair fidelity of DSBs was lower under Parp-1 deficiency. As for the former possibility, a possible explanation is that DNA polymerization or the displacement step of BER might be stalled in the absence of Parp-1 by the inefficient recruitment of repair proteins and DNA gaps may not be sealed efficiently and properly. The experiment with the in vitro reconstituted system showed that Parp-1 stimulates strand displacement and the removal process of long patch repair in the presence of FEN-1 (Prasad et al., 2001) . It is generally postulated that the stalled, gapped DNA intermediates in BER could possibly develop into DSBs (Harrison et al., 1999; Vispe et al., 2003) . The DSBs might also be induced at a higher frequency in the absence of Parp-1 after treatment of BHP by stalled replication forks caused by the damaged bases, leading to a collapse of the holiday structure. It is shown that, in Parp-1 À/À cells, the repair of stalled replication forks is delayed (Yang et al., 2004) . Another possibility for generation of DSB after BHP treatment is that, in order to remove massive alkylated bases, abortive mismatch repair (Branch et al., 1993) or base excision repair (Blaisdell and Wallace, 2001 ) might occur and excessive incision reactions on DNA may result in introduction of DSBs.
The second possibility, namely lower fidelity of DSB repair under Parp-1 deficiency, could be explained as follows. DSBs could be repaired mostly by either NHEJ or HR (Valerie and Povirk, 2003) , and, because we found no long homology in the junctional sequences of any of the analysed simple deletion mutants, we suggest that most of the deletion mutations might be generated during NHEJ repair. The major process of NHEJ is catalysed by DNA-PKcs and the Ku70/80 complex. In the presence of both DNA-PKcs and Parp-1, autophosphorylation of DNA-PKcs is stimulated by Parp-1 (Ariumi et al., 1999) . Parp-1 might also protect DSB termini from nuclease attack because polyADP-ribosylation of Ku70/80 reduces exonuclease activity of WRN in vitro (Li et al., 2004) and contributes to efficient recruitment and activation of DNA-PK complexes. It is thus speculated that the recruitment of DNA-PKcs or its activity could not be controlled in the absence of Parp-1, resulting in low fidelity of NHEJ repair. (Paull and Gellert, 2000; Oshima et al., 2002; Lieber et al., 2003) . When both ends reach a microhomologous sequence of 2-5 bases, excision of DNA is stopped and annealing occurs. After removing protruding single-stranded ends, ligation of both the strands occurs and the end-joining process is completed (Roth and Wilson, 1986) . (b) Non-MEJ: Both DNA termini are either blunt ended when DSB occurred or processed to become blunt ended by nucleases. Then, both DNA ends may be held together by DNA-PKcs, Ku70/80, XRCC4 complex, and ligation of DNA ends will be carried out, probably by DNA ligase IV (Roth and Wilson, 1986) Increase of deletion mutations under Parp-1 deficiency A Shibata et al Nucleotide positions (as indicated by asterisk) in lambda EG10. k, the position of the deletion junctions. The upper red line indicates 'Cttca' sequences at deletion junctions, which is common to Ls4 G80-1-2 and Ls4 G86-2-6.
Increase of deletion mutations under Parp-1 deficiency NHEJ is further classified into MEJ and non-MEJ; the former harbors some microhomology at DSB termini, whereas the latter harbors no microhomology (Figure 4) . To ask whether the deletion mutations observed in Parp-1 À/À and Parp-1 þ / þ mice were caused through MEJ or non-MEJ, we categorized the Spi À mutants and calculated the fraction of MEJ frequency to total NHEJ events. The fraction is decreased to approximately half that in Parp-1 À/À (26%) compared with that in Parp-1 þ / þ mice (43%). We also found that the frequency of complex-type deletions accompanying 1-5 bp insertions or recombination/rearrangement is substantially increased (Po0.05), namely, 16/73 (22%) of the mutants in Parp-1 À/À compared to 2/32 (6%) of those in Parp-1 þ / þ cases (Table 4 ). In most of these cases, the deletion junction did not harbor microhomology. These results suggest that DNA ends may be destabilized in the absence of Parp-1 and allow accidental insertion or recombination/rearrangement in non-MEJ processes. The introduction of small insertions in deletion junctions could be caused by polymerase l (pol l) and pol m, which facilitate filling of a few bases gap in the NHEJ, and terminal deoxynucleotidyl transferase (TdT), which is also involved in the NHEJ event of V(D)J recombination (Garcia-Diaz et al., 2002; Bebenek et al., 2003) . In the absence of Parp-1, these error-prone DNA polymerases might easily modify these DNA ends, resulting in small insertions, namely nontemplated nucleotides.
Three of six mutants with small insertions contained 'palindromic (P) nucleotides' at deletion junctions under Parp-1 deficiency (Table 4) . 'P nucleotides' are possibly introduced by self-complementary single-strand extensions during the DSB repair process of V(D)J recombination, and slightly longer 'P nucleotides' insertions at a higher frequency could be observed in the deletion mutations of SCID mice (Ding et al., 2003) . The present results suggested the possibility that 'P nucleotides' may be preferentially introduced during NHEJ repair under Parp-1 deficiency, possibly through the destabilization of DNA ends.
A higher frequency (10/73) of deletion mutations accompanying recombination/rearrangement was observed in Parp-1 À/À animals than in Parp-1 þ / þ animals (2/32) as shown in Table 4 , although it is not statistically significant (P>0.05). Ls4 G86-2-6 mutation in Table 5 was suggested to involve two sequential recombinations using 8-10 bp homology (underlined). There is a possibility that this mutation could be caused by the switchover of NHEJ to HR repair during processing of DSBs. The possible involvement of Parp-1 in the regulation of switching from NHEJ to HR should be further investigated, because the elevated frequency of HR including gene targeting (Semionov et al., 2003) and SCEs (de Murcia et al., 1997) was reported previously in the absence of Parp-1 or by Parp-1 inhibition.
We observed more deletion mutations (P ¼ 0.082), especially those more than 1 kbp (Po0.05), and complex-type deletions accompanying either insertion or recombination/rearrangement (Po0.05) in Parp-1 À/À mice. We suggested that this indicates that Parp-1 prevents these types of genomic changes. In vitro studies showed that Parp-2 also facilitates BER by interacting with DNA repair proteins such as XRCC1 (Schreiber et al., 2002) ; however, the present result suggests that the role of Parp-1 in preventing these types of mutations could not be fully compensated by Parp-2 or other molecules engaged in DNA repair. It is reported that interstitial deletions in human cancer could be preferentially produced through NHEJ repair processes (Sasaki et al., 2003) , suggesting the substantial contribution of deletion mutation to carcinogenesis. Although the increase of Spi À mutant frequency by Parp-1 deficiency is only 1.6-fold (Po0.05), this difference may evoke a significant impact on multi-step carcinogenesis (Doll, 1962; Sugimura, 1992) . For example, if mutation in five genes is necessary for cancer development, the difference in the frequency of achieving all the five mutations between Parp-1 þ / þ and Parp-1 À/À mice is calculated to be 10-fold. The impact of Parp-1 deficiency on deletion mutation might be different among tissues and DNA-damaging insults; however, the present results suggest a substantial role of Parp-1 in the maintenance of genomic stability, which may be important not only for carcinogenesis but also for various pathogenic processes. The results also raise a caution on the therapeutic use of Parp-1 inhibitors, and basic studies should be carried out carefully to avoid any possible risks to causing somatic or germ-cell mutations by Parp-1 inhibition.
Materials and methods

Establishment of
Homozygous gpt delta transgenic mice of C57BL/6 genetic background (Nohmi et al., 1996) were mated with Parp-1 À/À mice of ICR/129Sv mixed genetic background , and Parp-1 þ /-mice homozygous for the lambda EG10 transgene (Parp-1 þ /-/gpt delta mice) were obtained. By intercrossing Parp-1 þ /-/gpt delta mice, we obtained Parp-1
Animal treatment
Spontaneous mutant frequencies in the bone marrow and livers were analysed as follows. Male Parp-1 þ / þ and Parp-1 À/À mice (n ¼ 5, respectively) were fed a basal diet (CE-2, Clea Japan), anesthetized, and killed at the age of 16 weeks. The bone marrows and livers were immediately frozen in liquid nitrogen, and stored at À801C until DNA extraction. BHP (Nakalai Tesque) was dissolved in saline, adjusted to 0.2 g/ml, and sterilized by filtration. Four Parp-1 À/À /gpt delta and four Parp-1 þ / þ /gpt delta male mice received an intraperitoneal injection of BHP at 2 g/kg body weight (bw) at the age of 16 weeks. All animals were killed 1 week after BHP administration, and the livers were frozen and stored as described above. Genomic DNAs were extracted from the bone marrows and livers by standard phenol/chloroform extraction or the dialysis method performed with a RecoverEase DNA isolation kit (Stratagene). A lambda phage in vitro packaging reaction was carried out with Transpack Packaging Extract (Stratagene). The experimental protocol was approved by the Ethics Review Committees for Animal Experimentation of the participating institutions.
gpt assay
The gpt assay (Figure 1 ) was performed as described previously (Nohmi et al., 1996) . Briefly, the phages rescued from genomic DNAs were transfected into E. coli YG6020 expressing Cre recombinase. Infected cells were cultured at 371C on plates containing chloramphenicol (Cm) and 6-thioguanine (6-TG) for 3 days until 6-TG-resistant colonies appeared. To confirm the 6-TG-resistant phenotype, colonies were restreaked on plates containing Cm and 6-TG. Confirmed 6-TG-resistant colonies were cultured, and bacterial pellets were collected by centrifugation. The average background mutant frequency in the gpt assay was 1 Â 10
À6
. The predominant type of the background mutations is insertion of transposable element, IS1 of E. coli, and is distinguishable from the mutations generated in mice . As no IS1 insertion mutations were observed in our collection of gpt mutations recovered from mice, they were suggested to be originated in mice but not in E. coli host. The data for mutant frequencies in gpt assay were therefore presented without subtracting the average background mutant frequencies.
A 739 bp DNA fragment encompassing the gpt gene was amplified by PCR as described previously . DNA sequencing of the gpt gene was performed with a CEQt DTCS Quick Start Kit (Beckman Coulter).
Spi
À assay
An Spi À assay (sensitive to P2 interference) (Nohmi et al., 1996) was carried out with a slight modification as described previously (Shibata et al., 2003) . The frequencies of background mutants were less than 10 À8 in Spi À assay and was neglectable. The data for Spi À mutant frequencies were therefore presented without subtracting the background mutant frequencies. Spi À mutant phages were infected to E. coli LE392 and phage DNA was purified by Quantum Prep s AquaPure Genomic DNA Kit (Bio-Rad).
Analysis of mutation spectra in the Spi À mutants
To determine the mutated region, lysates of Spi À mutant phage or the phage DNA were used and subjected to PCR analysis with various sets of primers Okada et al., 1999) . To narrow down the mutated region, the structure of each mutation was also analysed by digesting Spi À mutant DNA with restriction enzymes and by comparing the lengths of the produced fragments with those expected for wild-type lambda EG10 DNA. We also adapted a Southern blot hybridization method that uses oligonucleotide DNA probes (Shibata et al., 2004) . Briefly, 10 mg of oligomers, 25-36 nucleotides long, were spotted onto Hybondt-N (Amersham Pharmacia Biotech), and after crosslinking by UV (1200 J/m 2 , Stratagene) the membrane was soaked into a hybridization buffer consisting of 10 Â Denhardt's solution, 2 Â SSC, and 100 mg/ml denatured salmon sperm DNA at 421C for 2 h. As the probe of each clone, the 15 kb region spanning the red/gam genes of each Spi À mutant was amplified by PCR with the primers 18874R and 32890F (Shibata et al., 2004) , and was labeled with [a 32 P]dCTP using the Megaprime DNA Labeling System (Amersham Pharmacia Biotech). Hybridization was performed overnight at 371C, and the membrane was washed three times each for 1 h at 371C with a buffer containing 2 Â SSC, 0.1% SDS, and 7.5 mM pyrophosphate, and the radioactivity of each oligomer spot was analysed by BAS 2500 (Fuji Film) . This method permits the identification of where a deletion occurred and its approximate length. When there is a deletion associated with an insertion, then one or more of the probes does not give a signal, but the PCR product is bigger than expected.
Statistical analysis
The statistical significance of differences in mutant or mutation frequencies between the two groups was analysed using the Mann-Whitney U-test. The differences of the frequencies of simple deletion and complex-type deletion between genotypes were analysed by Fisher's exact test.
